跳至主要内容
临床试验/NCT06261086
NCT06261086尚未招募不适用

Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study

Sohag University0 个研究点目标入组 90 人开始时间: 2024年2月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
主要终点
GASDM-D

研究概览

简要总结

Vitiligo is an acquired pigmentary disorder on skin and/or mucosae, which is characterized by death of melanocytes (MCs), affecting 0.5%-2% of the population worldwide (1). It doesn't affect the health of patients but it has marked social pressure and greatly interfere with their quality of life (2,3). It presents with well circumscribed milky white patches that occur secondary to destruction of melanocyte, it may appear at any age and affect both sexes equally.

It can affect ethnic groups and people of all skin types with no predilection (4).

Clinically, several types of vitiligo are distinguished according to the distribution of the achromic lesions. One or more lesions in a dermatomal pattern are characteristic for segmental vitiligo (SV) while this segmental distribution is absent in non-segmental vitiligo (NSV). The latter variety includes both the focal type and the generalized type (5). Numerous previous studies tried to illustrate the pathogenesis behind the disease, but the exact pathophysiology is still not fully understood. It is a multifactorial disease. Factors include, neural theory, oxidative stress theory, autoimmune hypothesis, intrinsic theory, melanocytorrhagy hypothesis (6). Many theories tried to explain the mechanisms of MC destruction in vitiligo. Apoptosis is one of the most widely studied cell death pathways. In addition, the other two forms of cell death, conventional necrosis and autophagy seem to be involved in the death of vitiligo MCs under certain situations. Moreover, new types of regulated cell death including necroptosis, pyroptosis, and ferroptosis may also participate in the pathogenesis (7). Pyroptosis is a highly inflammatory form of necrosis cell death NCD regulated mainly by caspase-1, which is initiated following large supramolecular complex ermed inflammasome activation (8). The inflammasome-activated Caspases then cleave the pyroptosis-inducing protein Gasdermin D (GSDMD), which forms a pore in the plasma membrane and causes cell lysis as well as the secretion of IL-1β typically (9). Another study suggests that inflammasome activation could be a useful marker for assessing disease progression of vitiligo (10). However, the link between vitiligo and inflammasome activation is still unclear. The inflammasome regulates cell death and inflammation via activation of caspase-1 (11). The activation of caspase-1 promotes the secretion of proinflammatory cytokines IL-1β and IL-18, as well as the initiation of pyroptosis (12). So, evaluation of pyroptosis-related indicators (GASDM-D, IL 1β & IL-18) may help understanding the obscure inflammasome pathway involvement in the pathogenesis of Vitiligo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with vitiligo ≥ 18 years old, both male and female patients will be included.

排除标准

  • Patients with the following criteria will be excluded from our study:
  • Pregnancy and breast-feeding women
  • patients on antioxidants or anti-inflammatory drugs
  • Patients on topical/systemic treatment for vitiligo in the last 4weeks prior to enrollment in the study
  • Patients with other dermatological diseases as psoriasis, lichen planus, viral infection, etc.
  • Patients suffering from chronic medical illness such as; diabetes mellitus, thyroid disease, and cancer.

研究组 & 干预措施

patient with vitiligo group

Active Comparator

Patients with vitiligo ≥ 18 years old, both male and female patients will be included.

Exclusion criteria:

Patients with the following criteria will be excluded from our study:

  1. Pregnancy and breast-feeding women.
  2. patients on antioxidants or anti-inflammatory drugs
  3. Patients on topical/systemic treatment for vitiligo in the last 4weeks prior to enrollment in the study
  4. Patients with other dermatological diseases as psoriasis, lichen planus, viral infection, etc.
  5. Patients suffering from chronic medical illness such as; diabetes mellitus, thyroid disease, and cancer.

干预措施: evaluate serum levels pyroptosis-related indicators (GASDM-D, IL 1β & IL-18) (Diagnostic Test)

control group

Active Comparator

control criteria with the following criteria will be excluded from our study:

1- Pregnancy and breast-feeding women.

干预措施: evaluate serum levels pyroptosis-related indicators (GASDM-D, IL 1β & IL-18) (Diagnostic Test)

结局指标

主要结局

GASDM-D

时间窗: 6 months

Evaluartion of serum level of (GASDM-D) in patients with Vitiligo as well as in control health group. 2- To correlate level of GASDM-D with severity of the disease.

IL 1β

时间窗: 6 months

Evaluation of serum level of IL 1β in patients with Vitiligo as well as in control health group 2- To correlate level of IL 1β with severity of the disease.

IL-18

时间窗: 6 months

Evaluation of serum level of IL-18 in patients with Vitiligo as well as in control health group 2- To correlate level of IL-18 with severity of the disease.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Abdelmawla Mohamed

resident of dermatology department at psychatric hospital

Sohag University

相似试验

Evaluation of Pyroptosis-related Indicators in the... | 临床试验